First-in-class drug ONC201 shows potential for some blood cancers
Wednesday, February 17, 2016 - 14:28
in Health & Medicine
ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia (AML), according to a recent clinical study.